Proof of concept: anti-EPCAM gold nanorods and femtosecond laser pulses for retinoblastoma treatment

Nir Katchinskiy; Roseline Godbout; Ali Hatef; Abdulhakem Y. Elezzabi

doi:10.1117/12.2306966

17 May 2018 Proof of concept: anti-EPCAM gold nanorods and femtosecond laser pulses for retinoblastoma treatment

Nir Katchinskiy, Roseline Godbout, Ali Hatef, Abdulhakem Y. Elezzabi

Proceedings Volume 10685, Biophotonics: Photonic Solutions for Better Health Care VI; 106850I (2018) https://doi.org/10.1117/12.2306966
Event: SPIE Photonics Europe, 2018, Strasbourg, France

Abstract

Retinoblastoma is a retinal cancerous disease that primarily affects young children. To date, preservation of the eye and its functionality is secondary to saving the child’s life. EpCAM+ Y79 retinoblastoma cells behave like cancer stem cells that are recognized as cells that are resistant to treatment. Additionally, reoccurrence of tumours is attributed to the persistence of cancer stem cells. An effective technique to treat retinoblastoma cancer cells is demonstrated using femtosecond laser pulses and EpCAM targeting gold nanorods (Au-NRs). Both fluorescence viability assay and MTS cellular metabolism assay confirm an astonishing cellular viability drop, to ~10%. It is shown that right after laser irradiation the cellular membrane ruptures. FESEM imaging shows that Au-NRs reach melting temperature after laser pulse exposure. The medium of the eye is transparent to NIR laser irradiation, making this treatment ideal for this type of cancer. This treatment methodology would also be an invaluable tool for treatment of chemotherapy-resistant and radiation-resistant cancers.

Conference Presentation

Citation Download Citation

Nir Katchinskiy, Roseline Godbout, Ali Hatef, and Abdulhakem Y. Elezzabi "Proof of concept: anti-EPCAM gold nanorods and femtosecond laser pulses for retinoblastoma treatment", Proc. SPIE 10685, Biophotonics: Photonic Solutions for Better Health Care VI, 106850I (17 May 2018); https://doi.org/10.1117/12.2306966

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available